Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 16, 2020European Journal of Heart FailureOpen Access

Predictors of Sudden Cardiac Death in High-Risk Patients Following a Myocardial Infarction

View Full Paper
Ask AI
Bookmark
Share

Why the study?

The study was conducted to develop a risk model for sudden cardiac death in high-risk acute myocardial infarction survivors.

Population

13 202 high-risk AMI survivors from CAPRICORN and VALIANT with validation in EPHESUS

Design

Risk model derivation and validation study

Follow-up

Median 2.0 years

Authors

KDKieran F. DochertyHeart Failure / Cardiomyopathy
João Pedro Ferreira
João Pedro FerreiraHeart Failure / Cardiomyopathy
ASAbhinav SharmaGovernment Medical College

Discussion

Loading...

Member takes

Implication

May aid post-AMI SCD risk stratification; leaves open prospective validation before clinical use.

Structured PICO

P
Population
19,834 patients (13,202 in derivation cohort, 6,632 in validation cohort) with left ventricular systolic dysfunction, heart failure, or both, enrolled between 12 hours and 21 days following an acute myocardial infarction. Mean age 64.1 years, 29.8% female.
O
Outcome
Sudden cardiac death (SCD) with non-SCD as a competing risk over a median follow-up of 2.0 yearshard clinical

An 11-variable clinical risk score predicts sudden cardiac death in high-risk acute myocardial infarction survivors significantly better than left ventricular ejection fraction alone.

Limitations

  • Post-hoc analysis of clinical trial patients (selected population)
  • Differing definitions of SCD and maximum time from AMI to randomization across trials
  • Unable to account for implantable cardioverter defibrillator use following randomization
  • Missing variables such as potassium and treatment with RAAS inhibitors or beta-blockers
  • Trials are over 15 years old and may not represent contemporary clinical practice

Cite This Study

Docherty et al. (2020) studied this question.

synapsesocial.com/papers/6a7cc404041f7ddee0ba6980https://doi.org/10.1002/ejhf.1694

Topics

HFrEF treatmentHeart failure
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial2009 · 57 citations
  2. 2Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both2005 · 796 citations
  3. 3Design and Methodology of the CAPRICORN Trial — A Randomised Double Blind Placebo Controlled Study of the Impact of Carvedilol on Morbidity and Mortality in Patients with Left Ventricular Dysfunction After Myocardial Infarction2000 · 60 citations
  4. 4Smoking Status and Risk for Recurrent Coronary Events after Myocardial Infarction2002 · 213 citations
  5. 5Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction2004 · 1,528 citations